T-Y. Yang

The ERK–ZEB1 pathway mediates epithelial–mesenchymal transition in pemetrexed resistant lung cancer cells with suppression by vinca alkaloids

Leo Kai‐Ming Chiu, I-L Hsin, T-Y. Yang et al. · Oncogene · 2016 · 109 citations · Full text

LBA55 Trastuzumab deruxtecan (T-DXd) in patients (Pts) with HER2-mutant metastatic non-small cell lung cancer (NSCLC): Interim results from the phase 2 DESTINY-Lung02 trial

Keiko Goto, K. Sang-We, Takafumi Kubo et al. · Annals of Oncology · 2022 · 59 citations · Full text

Destiny-lung02 Trial, Medicine, Immunology +10

The effects of an injury to the brain on bone healing and callus formation in young adults with fractures of the femoral shaft

T-Y. Yang, T.-Y. Wang, Y-H. Tsai et al. · Journal of Bone and Joint Surgery - British Volume · 2012 · 44 citations

Skeletal Trauma, Traumatic Brain Injury, Young Adults +14

LncRNA SND1-IT1 accelerates the proliferation and migration of osteosarcoma via sponging miRNA-665 to upregulate POU2F1.

X-M Jin, Bin Xu, Y Zhang et al. · PubMed · 2019 · 24 citations

514MO Acquired mechanisms of resistance to first-line (1L) osimertinib with or without platinum-based chemotherapy (CT) in EGFR-mutated (EGFRm) advanced NSCLC: Preliminary data from FLAURA2

Chee Khoon Lee, Jacqulyne Robichaux, Pasi A. Jänne et al. · Annals of Oncology · 2023 · 15 citations · Full text

Medicine, Pharmacology, Acquired Mechanisms +9